# 32 Biosciences

> 32 Biosciences ("Three Squared") is a North Chicago, Illinois gastrointestinal biotechnology
> company founded in 2023, pioneering gut mucosal-immune science to prevent and treat GI disease.
> It runs a GI Discovery Platform measuring metabolomic signatures of gut mucosal-immune function
> and a CS Therapeutic Platform whose lead asset CS-0003 is a Mucosal Immune Modulator.

IMPORTANT: 32 Biosciences publishes no product API, no developer portal and no documentation for
developers. This file was GENERATED by API Evangelist from the company's own public website and
from the WordPress route-discovery document its site serves; it is not published by the company and
is not served at https://32biosciences.com/llms.txt (that path returns HTTP 404).

## Company

- [Homepage](https://32biosciences.com/): company overview, platforms and pipeline.
- [Our Story](https://32biosciences.com/our-story/): founding, mission, prevention-first thesis.
- [Team](https://32biosciences.com/team/): leadership, board and scientific advisory board.
- [Technology](https://32biosciences.com/technology/): gut mucosal-immune science.
- [Therapeutic Platform](https://32biosciences.com/therapeutic-platform/): CS Therapeutic Platform, lead asset CS-0003, a Mucosal Immune Modulator across seven indications.
- [Discovery Platform](https://32biosciences.com/diagnostic-platform/): GI Discovery Platform, metabolomic signatures of gut mucosal-immune function.
- [Pipeline & Proof of Concept](https://32biosciences.com/pipeline-proof-of-concept/)
- [Investor Relations](https://32biosciences.com/investor-relations/)
- [Contact](https://32biosciences.com/contact/): 3333 Green Bay Rd, Suite 210, North Chicago, IL 60064; info@32biosciences.com.

## News

- [News & Updates](https://32biosciences.com/news-updates/)
- [News Releases](https://32biosciences.com/category/news-releases/): 12 posts.
- [Features](https://32biosciences.com/category/features/): 7 posts.
- [RSS feed](https://32biosciences.com/feed/)

## Machine-readable surface

The only machine-readable surface on 32biosciences.com is the WordPress REST API. It is anonymously
readable for content and requires WordPress Application Passwords for every write.

- [Route discovery document](https://32biosciences.com/wp-json/): the WordPress route index, 291 routes across 15 namespaces.
- [Posts](https://32biosciences.com/wp-json/wp/v2/posts): news releases and features as JSON (12 items).
- [Pages](https://32biosciences.com/wp-json/wp/v2/pages): marketing, platform and profile pages (37 items).
- [Media](https://32biosciences.com/wp-json/wp/v2/media): media library (230 items).
- [Categories](https://32biosciences.com/wp-json/wp/v2/categories) and [Tags](https://32biosciences.com/wp-json/wp/v2/tags)
- [Search](https://32biosciences.com/wp-json/wp/v2/search?search=mucosal): site-wide search across posts and pages.
- [Users](https://32biosciences.com/wp-json/wp/v2/users): the four content authors.
- [oEmbed](https://32biosciences.com/wp-json/oembed/1.0/embed?url=https://32biosciences.com/)
- [Sitemap index](https://32biosciences.com/sitemap_index.xml)

Pagination is `page` + `per_page` (max 100) with `X-WP-Total` / `X-WP-TotalPages` response headers
and RFC 5988 `Link` rel="next". Errors use the WordPress envelope `{code, message, data.status}`.

## Not available

- No OpenAPI, AsyncAPI, GraphQL, gRPC or SOAP contract is published by the company.
- No MCP server, no A2A agent card, no webhooks, no /.well-known documents (every path returns 404).
- No SDKs, CLI, sandbox, status page, changelog, pricing page or published rate limits.
- `/wp/v2/comments` returns HTTP 403 `rest_comment_disabled`; `/wp/v2/settings` and the
  `wp-abilities/v1` registry return HTTP 401 `rest_forbidden` anonymously.

## Optional

- [LinkedIn](https://www.linkedin.com/company/32biosciences)
- [Privacy Policy](https://32biosciences.com/privacy-policy/)
- [Cookie Policy](https://32biosciences.com/cookie-policy/)
- [Accessibility Statement](https://32biosciences.com/accessibility-statement/)
- [Conflict of Interest Policy](https://32biosciences.com/conflict-of-interest-policy/)